Asia Pacific Central Lab Market Size & Outlook, 2023-2030
Asia Pacific central lab market, 2018-2030 (US$M)
Related Markets
Asia Pacific central lab market highlights
- The Asia Pacific central lab market generated a revenue of USD 718.6 million in 2023.
- The market is expected to grow at a CAGR of 7.6% from 2024 to 2030.
- In terms of segment, biomarker services was the largest revenue generating services in 2023.
- Genetic Services is the most lucrative services segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 718.6 million |
| Market revenue in 2030 | USD 1,201.9 million |
| Growth rate | 7.6% (CAGR from 2023 to 2030) |
| Largest segment | Biomarker services |
| Fastest growing segment | Genetic Services |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services |
| Key market players worldwide | LabConnect, Eurofins Scientific SE, A. P. Moller Maersk A/S ADR, ACM Global, Cerba Research, Synevo Central Labs, Versiti, Cenetron, Ampersand Capital Partners, Pacific Biomarkers, Cirion |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 21.9% of the global central lab market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,201.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Central Lab Market Scope
Central Lab Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific central lab market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central lab market will help companies and investors design strategic landscapes.
Biomarker services was the largest segment with a revenue share of 38.45% in 2023. Horizon Databook has segmented the Asia Pacific central lab market based on genetic services, biomarker services, microbiology services, anatomic pathology/histology, specimen management & storage, special chemistry services covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is expected to witness significant growth due to increasing adoption of central lab services in the region. This can be attributed to rapid economic growth and an increase in R&D investment by countries, such as China and Japan, which has led to a rise in the number of clinical trials conducted.
Moreover, the cost of clinical trials in developing countries is lower than that in developed countries, which increases the need for clinical trial support in the region.
The increasing prevalence of target diseases, such as cancer and Alzheimer’s disease, is anticipated to propel the growth of Asia Pacific market in the coming years. For instance, according to IARC, in 2020, Asia accounted for 5.8 million cancer-associated deaths and 9.5 million new cancer cases.
Reasons to subscribe to Asia Pacific central lab market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific central lab market databook
-
Our clientele includes a mix of central lab market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific central lab market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific central lab market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific central lab market size, by country, 2018-2030 (US$M)
Asia Pacific Central Lab Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
